Overview and Scope
Large volume parenteral (LVP) refers to sterile intravenous solutions of a volume of 100 ml or more that are terminally sterilized by heat. They are used for intravenous infusions to administer hydration, nourishment, and medicine.
Sizing and Forecast
The large volume parenteral (lvp) market size has grown strongly in recent years. It will grow from $11.42 billion in 2023 to $12.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, growth in the aging population, rising demand for sterile pharmaceuticals, expansion of healthcare infrastructure, development of regulatory frameworks for pharmaceuticals.
The large volume parenteral (lvp) market size is expected to see strong growth in the next few years. It will grow to $17.35 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing demand for biologics and biosimilars, rising healthcare expenditure, expansion of pharmaceutical outsourcing, increasing focus on personalized medicine, globalization of pharmaceutical supply chains. Major trends in the forecast period include technological advancements in manufacturing processes, integration of advanced technologies in pharmaceutical production, implementation of single-use technologies, development of high-concentration formulations, rise in 3d printing applications for pharmaceuticals.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Segmentation & Regional Insights
The large volume parenteral (lvp) market covered in this report is segmented –
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
North America was the largest region in the large volume parenteral (LVP) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp
Major Driver Impacting Market Growth
The growing prevalence of chronic diseases is expected to propel the growth of the large-volume parenteral market going forward. Chronic diseases refer to a sickness or condition that typically lasts three months or longer and can potentially worsen over time. The rise in chronic diseases is mainly driven by tobacco use, being around smoke, and poor nutrition. These patients must require an appropriate ratio of essential nutrients that support the maintenance of strength, and the parenteral mode of administration facilitates the correct pharmaceutical dosage because most of the drug is directly absorbed in circulation, skipping the digestive system. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that in the US by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases drives the growth of the large-volume parenteral market.
Key Industry Players
Major companies operating in the large volume parenteral (lvp) market report are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.
The large volume parenteral (lvp) market report table of contents includes:
1. Executive Summary
2. Large Volume Parenteral (LVP) Market Characteristics
3. Large Volume Parenteral (LVP) Market Trends And Strategies
4. Large Volume Parenteral (LVP) Market – Macro Economic Scenario
5. Global Large Volume Parenteral (LVP) Market Size and Growth
.
.
.
32. Global Large Volume Parenteral (LVP) Market Competitive Benchmarking
33. Global Large Volume Parenteral (LVP) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Large Volume Parenteral (LVP) Market
35. Large Volume Parenteral (LVP) Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
